HIST1H4A | Histone cluster 1, H4a | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21887/48171_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
HLA-DRB5 | Major histocompatibility complex, class II, DR beta 5 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43151/101491_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
HTR3C | 5-hydroxytryptamine (serotonin) receptor 3C, ionotropic | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ICAM4 | Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images/67629/1258_F8_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
INMT | Indolethylamine N-methyltransferase | Enzymes Predicted intracellular proteins
| ![](/images/55180/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/55180/ihc_cell_selected_60x60.jpg) | ![](/images/55180/128088_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
IRX2 | Iroquois homeobox 2 | Predicted intracellular proteins Transcription factors
| ![](/images/54669/ihc_selected_60x60.jpg) | ![](/images/50895/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/54669/125409_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
IRX3 | Iroquois homeobox 3 | Predicted intracellular proteins Transcription factors
| ![](/images/62522/ihc_selected_60x60.jpg) | ![](/images/62522/1104_F10_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/62522/141033_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
IRX5 | Iroquois homeobox 5 | Disease related genes Predicted intracellular proteins Transcription factors
| ![](/images/47130/ihc_selected_60x60.jpg) | ![](/images/47130/1314_A6_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/47130/106777_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
ITGB6 | Integrin, beta 6 | Cancer-related genes Plasma proteins Predicted membrane proteins
| ![](/images/73536/155964_A_5_5_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/73536/155961_A_6_5_rna_selected_60x60.jpg) | Tissue enhanced |
KAL1 | Kallmann syndrome 1 sequence | Disease related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KCNS3 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/14864/ihc_selected_60x60.jpg) | ![](/images/14864/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14864/33788_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
KHDC1L | KH homology domain containing 1-like | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/500/873_A_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
KIR2DL1 | Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | CD markers Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KLRG2 | Killer cell lectin-like receptor subfamily G, member 2 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/18199/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18199/43533_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
LIMCH1 | LIM and calponin homology domains 1 | Predicted intracellular proteins
| ![](/images/63840/ihc_selected_60x60.jpg) | ![](/images/4184/if_selected_60x60.jpg) | | ![](/images/63840/143554_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
LRCOL1 | Leucine rich colipase-like 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
LRRK2 | Leucine-rich repeat kinase 2 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| ![](/images/14293/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14293/32797_B_1_1_rna_selected_60x60.jpg) | Tissue enhanced |
MARCO | Macrophage receptor with collagenous structure | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/63793/1411_D3_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/63793/143123_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MATN3 | Matrilin 3 | Disease related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MSR1 | Macrophage scavenger receptor 1 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/272/724_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
NCKAP5 | NCK-associated protein 5 | Predicted intracellular proteins
| ![](/images/34639/ihc_selected_60x60.jpg) | ![](/images/44859/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34639/79843_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
NDNF | Neuron-derived neurotrophic factor | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48881/123123_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
NINJ2 | Ninjurin 2 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images/58980/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
NKD2 | Naked cuticle homolog 2 (Drosophila) | Predicted intracellular proteins
| ![](/images/49463/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49463/112641_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
NOTCH4 | Notch 4 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
NPNT | Nephronectin | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/50203/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3711/10662_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
NTM | Neurotrimin | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24875/59596_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
OSCAR | Osteoclast associated, immunoglobulin-like receptor | Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images/62740/1487_H10_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
OVCH1 | Ovochymase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/40253/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40253/85619_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PCDHA12 | Protocadherin alpha 12 | Predicted membrane proteins
| ![](/images/35812/153065_B_8_8_selected_60x60.jpg) | ![](/images/35812/1305_F4_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/35812/153062_A_4_2_rna_selected_60x60.jpg) | Tissue enhanced |
PCSK9 | Proprotein convertase subtilisin/kexin type 9 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| ![](/images/25575/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25575/54047_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PRX | Periaxin | Disease related genes Plasma proteins Predicted intracellular proteins
| | ![](/images/1868/63_C5_1_selected_60x60.jpg) | ![](/images/1868/ihc_cell_selected_60x60.jpg) | ![](/images/1868/7444_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
PTPRQ | Protein tyrosine phosphatase, receptor type, Q | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/53245/ihc_selected_60x60.jpg) | ![](/images/53245/1331_C2_9_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53245/120117_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
RAMP3 | Receptor (G protein-coupled) activity modifying protein 3 | FDA approved drug targets Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
RS1 | Retinoschisin 1 | Disease related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
RSPO4 | R-spondin 4 | Disease related genes Predicted secreted proteins
| ![](/images/48887/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/48887/ihc_cell_selected_60x60.jpg) | ![](/images/48887/126202_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
S100A3 | S100 calcium binding protein A3 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SEC14L3 | SEC14-like 3 (S. cerevisiae) | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/59450/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/59450/ihc_cell_selected_60x60.jpg) | ![](/images/59450/133393_B_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
SEC14L6 | SEC14-like 6 (S. cerevisiae) | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/67695/1414_F6_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SHROOM4 | Shroom family member 4 | Disease related genes Predicted intracellular proteins
| ![](/images/10565/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10565/26221_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
SLC11A1 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 | Predicted membrane proteins Transporters
| ![](/images/29590/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29590/96871_A_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
SLC39A8 | Solute carrier family 39 (zinc transporter), member 8 | Predicted membrane proteins Transporters
| ![](/images/38833/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38833/81606_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
SLC6A14 | Solute carrier family 6 (amino acid transporter), member 14 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/3193/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3193/9071_A_1_4_rna_selected_60x60.jpg) | Tissue enhanced |
SMAD6 | SMAD family member 6 | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SOSTDC1 | Sclerostin domain containing 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SPOCK2 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | Predicted secreted proteins
| ![](/images/44605/ihc_selected_60x60.jpg) | ![](/images/44605/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44605/99745_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ST6GALNAC5 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Predicted secreted proteins
| ![](/images/70354/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70354/154045_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ST8SIA6 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/11635/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11635/28653_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |